Surgical treatment of retroperitoneal masses

Кригер, А. Г.; Берелавичус, С. В.; Son, A. I.; Gorin, D S; Akhtanin, E A; Калдаров, А. Р.; Smirnov, A. V.; Davydenko, P. I.; Kalinin, D. V.

doi:10.17116/hirurgia2017115-26

Khir. Z. im. N.I. Pirogova

2017

DOI: 10.17116/hirurgia2017115-26

|View full text |Cite

Surgical treatment of retroperitoneal masses

А. Г. Кригер

С. В. Берелавичус

A. I. Son

et al.

Abstract: Comprehensive evaluation of different surgical methods is necessary to achieve successful treatment of retroperitoneal tumors. Conventional approach is indicated for tumors over 10 cm while minimally invasive techniques are justified for tumors less than 10 cm. RA-interventions facilitates surgery for tumors located in difficult areas and small anatomical spaces as well as for neoplasms adjacent to great vessels.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2019

2024

Publication Types

Select...

Article5

Relationship

Self Cite1

Independent4

Authors

Journals

Cited by 5 publications

(1 citation statement)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These techniques have a shorter learning curve and result in better postoperative recovery, less blood loss, and shorter operation times compared to open surgeries [ 12 ] Robotic resection for tumors has limited published reports, mostly case studies. Despite advancements in robotic techniques, research on this topic is still limited [ 13 – 18 ]. Our study aims to compare the outcomes of robotic and open excision of retroperitoneal tumors.…”

mentioning

confidence: 99%

Open versus robot-assisted retroperitoneal tumors resection involving inferior vena cava, abdominal aorta, and renal hilum: a comparative study

Sulaiman,

Ali,

Chunguang

et al. 2024

Surg Endosc

View full text Add to dashboard Cite

Introduction Surgery is currently the only effective treatment for retroperitoneal tumors that do not involve any specific organ. The use of robots for removing both benign and malignant retroperitoneal tumors is considered safe and feasible. However, there is insufficient evidence to determine whether robotic retroperitoneal tumor resection (RMBRs) is superior to open retroperitoneal malignant resection (OMBRs). This study compares the short-term outcomes of robotic excision of benign and malignant retroperitoneal tumors with open excision of the same-sized tumors. Methods The study compared demographics and outcomes of patients who underwent robotic resection (n = 54) vs open resection (n = 54) of retroperitoneal tumors between March 2018 and December 2022. A 1:1 matching analysis was conducted to ensure a fair comparison. Results The study found that RBMRs resulted in reduced operative time (OT), estimated blood loss (EBM), and postoperative hospital stay (PSH) when compared to OBMRs. Additionally, RBMRs reduced EBL, PHS, and OT for patients with malignant tumor involvement in major vessels. No significant differences were found in tumor size, blood transfusion rate, and morbidity rate between the RBMRs and OBMRs groups. Conclusion When comparing RMBRs to OMBRs, it was observed that RMBR was associated with lower (EBL), shorter postoperative hospital stays (PHS), and reduced operative time (OT) in a specific group of patients with both benign and malignant tumors.

show abstract

mentioning

confidence: 99%

Open versus robot-assisted retroperitoneal tumors resection involving inferior vena cava, abdominal aorta, and renal hilum: a comparative study

Sulaiman,

Ali,

Chunguang

et al. 2024

Surg Endosc

View full text Add to dashboard Cite

show abstract

Robotic surgery in treatment of retroperitoneal tumors. Comparative single center study

et al. 2020

View full text Add to dashboard Cite

Surgical treatment of neurofibromatosis type I followed by retroperitoneal tumor

et al. 2019

Khir. Z. im. N.I. Pirogova

Self Cite

View full text Add to dashboard Cite

ФГБУ «Национальный медицинский исследовательский центр хирургии им. А.В. Вишневского» Минздрава России (дир.-акад. РАН А.Ш. Ревишвили), Москва, Россия РЕЗЮМЕ Нейрофиброматоз I типа (болезнь Реклингхаузена)-наследственное (аутосомно-доминантное заболевание), вызванное мутацией гена NF1. Опухоли брюшной полости и забрюшинного пространства при болезни Реклингхаузена встречаются редко. Цель исследования-выбор оптимального метода хирургического лечения у пациентов с проявлениями болезни Реклингхаузена в брюшной полости и забрюшинном пространстве. Материал и методы. В НМИЦ хирургии им. А.В. Вишневского хирургическое лечение выполнено 4 пациентам (3 женщины и 1 мужчина) с нейрофиброматозом I типа. Результаты. Выполнены 3 робот-ассистированные операции по удалению 2 неорганных забрюшинных опухолей (плексиформная нейрофиброма и шваннома) и 1 феохромоцитомы правого надпочечника. В исследование также включено одно клиническое наблюдение традиционного хирургического вмешательства по поводу множественных гастроинтестинальных стромальных опухолей двенадцатиперстной и тонкой кишки на фоне нейрофиброматоза I типа. В одном случае послеоперационный период осложнился формированием жидкостного скопления в ложе удаленной опухоли, что потребовало проведения дренирования под УЗ-контролем. В остальных случаях послеоперационный период протекал без осложнений. Заключение. Проведение робот-ассистированных операций в лечении проявлений нейрофиброматоза I типа в забрюшинном пространстве и брюшной полости безопасно и эффективно у пациентов с болезнью Реклингхаузена при наличии единичных образований. При множественных опухолях, расположенных в разных отделах забрюшинного пространства или брюшной полости, целесообразно выбирать традиционный вариант оперативного вмешательства. Ключевые слова: болезнь Реклингхаузена, плексиформная нейрофиброма, шваннома, феохромоцитома, гастроинтестинальная стромальная опухоль, робот-ассистированная операция.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Surgical treatment of retroperitoneal masses

Cited by 5 publications

References 13 publications

Open versus robot-assisted retroperitoneal tumors resection involving inferior vena cava, abdominal aorta, and renal hilum: a comparative study

Open versus robot-assisted retroperitoneal tumors resection involving inferior vena cava, abdominal aorta, and renal hilum: a comparative study

Robotic surgery in treatment of retroperitoneal tumors. Comparative single center study

Surgical treatment of neurofibromatosis type I followed by retroperitoneal tumor

Contact Info

Product

Resources

About